Becton, Dickinson and Company
BDX Healthcare Medical Instruments & Supplies
In the quarter to June 2026, revenue grew 5.44%, EPS fell 31.5%, free cash flow fell 31.6% and total debt fell 22.9%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for twenty-five consecutive years, revenue growth for three.
Follow BDX
Becton, Dickinson and Company (BDX) Operating cash flow
Becton, Dickinson and Company's operating cash flow for fiscal 2025 was $3.4B, down 10.8% from $3.8B in fiscal 2024. Over the twelve months to 30 June 2026 it was $4.0B. Over the past ten years it has ranged from $1.7B (fiscal 2015) to $4.1B (fiscal 2021); the current reading is higher than 82% of that period. Becton, Dickinson and Company ranks 1st of 54 Medical Instruments & Supplies companies by operating cash flow.
Operating cash flow, annual
Embed this chart
Annual newest first
| Period | Operating cash flow | Change |
|---|---|---|
| FY2025 | $3.4B | (10.77%) |
| FY2024 | $3.8B | 28.56% |
| FY2023 | $3.0B | 21.00% |
| FY2022 | $2.5B | (40.11%) |
| FY2021 | $4.1B | 40.48% |
| FY2020 | $2.9B | (11.80%) |
| FY2019 | $3.3B | 16.23% |
| FY2018 | $2.9B | 12.35% |
| FY2017 | $2.6B | (0.35%) |
| FY2016 | $2.6B | 47.92% |
Quarterly newest first
| Period | Operating cash flow | Change |
|---|---|---|
| Jun 2026 | $776.0M | 15.65% |
| Mar 2026 | $671.0M | 2.13% |
| Dec 2025 | $657.0M | (64.52%) |
| Sep 2025 | $1.9B | 70.06% |
| 42 more quarters | Free account |
Against its own ten years
Operating cash flow against peers
| Company | Operating cash flow |
|---|---|
| BDX Becton, Dickinson and Company | $4.0B |
| ISRG Intuitive Surgical, Inc. compare | $3.7B |
| MDLN Medline Inc. compare | $3.1B |
| ALC Alcon compare | $2.3B |
| RMD ResMed Inc. compare | $1.8B |
| BAX Baxter International Inc. compare | $1.3B |
| WST West Pharmaceutical Services, Inc. compare | $662.2M |
| SOLV Solventum Corporation compare | $209.0M |
| RGEN Repligen Corporation compare | $134.9M |
What Operating cash flow is
Operating Cash Flow shows how much cash a company’s day-to-day business actually brings in, after paying suppliers, staff and taxes.
Reported line item
More on BDX
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement